Accelerating BioVenture Innovation (ABI) (Phar 5009 01)
Weill Cornell Medicine BioVenture eLab Course
Help scientists and clinicians transform scientific discoveries into useful commercial
The ABI entrepreneurship course and training program is organized and sponsored by the
Weill Cornell Medicine Office of BioPharma Alliances & Research Collaborations and BioVenture eLab. ABI
is a 12-week program that builds teams around patented, unlicensed technologies from Weill Cornell Medicine,
Memorial Sloan Kettering Cancer Center and Rockefeller University. Teams will complete practice business
plans in the program around these technologies. Lectures will cover the process of evaluating the market
potential of a technology, building basic financial models, funding mechanisms, and writing and presenting a
business plan to potential investors. Lectures are open to members of Weill Cornell Medicine, Memorial Sloan
Kettering Cancer Center, Rockefeller University and the NYC healthcare community.
Satisfies 1 quarter elective. Credit or audit option available to Weill Cornell
Medicine graduate students and CTSC students. Audit option available to Rockefeller University affiliates.
Attendance (24%), competitive analysis (4%), budget & timeline (4%), elevator pitch (4%), improved elevator
pitch (4%), written business plan (20%) business model/financing (20%), business plan presentation (20%).
Tuesdays and/or Wednesdays, 6:00-7:30 PM: Belfer Research Building Rooms 204 or 302 (413 E.
69th St.), OR Weill Greenberg Center (1305 York Ave. Room A/B).
Larry Schlossman, Managing Director, BioPharma Alliances & Research Collaborations, Weill Cornell Medicine
Jessica Tabankin, Director, BioPharma Alliances & Research Collaborations, Weill Cornell Medicine
Jill Gold, Director, BioPharma Alliances & Research Collaborations, Weill Cornell Medicine
Jahan Ali, PhD, BioVenture eLab, Weill Cornell Medicine
Connor Dowling, BioVenture eLab, Weill Cornell Medicine
Daniel A. Heller, PhD, Professor, Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center
Steven S. Gross, PhD, Professor, Pharmacology, Weill Cornell Medicine
Dinali Wijewarnasuriya, Head Teaching Assistant, PhD Candidate, Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center
Carol Li, PhD Candidate, Weill Cornell Medicine
Alba Chacon, PhD, Postdoc Researcher, Memorial Sloan Kettering Cancer Center